• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding

    The Baseline

    12
    Following
    368
    Stocks Tracked
    49
    Sectors & Interests
    Follow
    Load latest
    logo
    The Baseline
    19 Jul 2024
    Five Interesting Stocks Today - July 19, 2024

    Five Interesting Stocks Today - July 19, 2024

    1. Avenue Supermarts (DMart):

    This department store company has been rising in the past week after its quarterly results for Q1FY25. The company saw revenue growth of 19% YoY to Rs 14,111 crore, surpassing Trendlyne’s Forecaster estimates by 1.5%. However, its net profit fell short of estimates by 3.8%, despite increasing by 17.5% YoY to Rs 773.8 crore.

    The net profit jump was driven by higher revenue from the discretionary segment. DMart’s general merchandise and apparel segment saw an uptick, driven by a growing number of DMart Ready outlets. But high EBITDA margins were offset by higher operating costs, due to investments in service sales and future capacity building. DMart added six new stores in Q1, bringing its total to 371.

    The company, like many others, has been facing heat from  quick commerce players like Zepto and Blinkit. Trent’s Zudio  has also emerged as a competitor in the value apparel segment. Neville Noronha, CEO of Avenue Supermarts, said, “We aim to open new stores as quickly as possible, but our main focus remains on how well the newly opened stores are being managed.”

    The company currently trades in the PE Neutral Zone. However, even at this neutral level, its PE stands at 123, which is higher than the industry average. The company appears in a screener of stocks with annual profit growth higher than sector growth.

    Prabhudas Lilladher downgraded DMart’s rating to ‘Accumulate’ as the company missed net profit and margin estimates. However, the brokerage is upbeat about the company’s sustained focus on tier-2 and tier-3 cities, and further acceleration in store openings in the coming years. They expect addition of 45-50 stores in FY25  to drive a 21% sales growth and anticipate a net profit CAGR of 25% over FY25-26.

    2. Asian Paints:

    This paint maker fell 1.4% on Thursday after announcing Q1 results. Asian Paints’ net profit surprised investors by declining sharply, down 24.5% YoY to Rs 1,170 crore, and missing Forecaster estimates by 15.6%. Revenue was down 2.3% YoY during the quarter. The weak profit performance was due to previously taken price cuts, higher raw material prices and employee benefit expenses, as well as restricted supply chains due to heatwaves. 

    During the quarter, domestic business, contributing around 97% to the revenue, grew by 5.9% YoY. Domestic business includes decorative and industrial segments. The decorative segment was impacted due to raw material price inflation and supply chain challenges. 

    Raw material prices were up 1.8% YoY in Q1FY25 and are expected to rise further, around 1.5% in Q2. Asian Paints announced a 0.7-1% price hike on July 10 to offset these costs, and more hikes are likely in the upcoming quarter. The industrial segment, however, outpaced decoratives, led by growth in auto OEM and powder coatings. Meanwhile, international business (constituting over 3% of the revenue) fell by 3.6% YoY due to underperformance in key markets including Nepal, Bangladesh, and Egypt. 

    The paint industry faces both cost and competitive pressures and potential market share shifts, especially with the entry of Aditya Birla Group’s Birla Opus. The next few quarters are crucial to assess the impact of Birla Opus on the industry as a whole, and on Asian Paints.

    The management highlighted that April and May were challenging months, while June saw some demand recovery, particularly in rural areas. Speaking on the outlook, Amit Syngle, the MD and CEO, said “We are seeing some green shoots in rural areas, and the progression of the monsoon is expected to support this uptick”. He adds that growth in T3 and T4 cities outpaced T1 and T2 cities. Syngle also highlights that the upcoming festive season will drive growth for the company.

    Motilal Oswal has a ‘Neutral’ rating with a target price of Rs 3,150. The brokerage expects muted revenue growth due to price cuts and competitive pressure, despite initiatives to improve volumes. The company is in the PE Buy Zone, indicating it is currently trading below its historical PE.

    3. Jubilant Ingrevia

    This specialty chemicals company fell by 6.6% over the past week and announced its results on Tuesday. For Q1FY25, the company’s net profit declined by double digits, down 15.4% YoY to Rs 48.7 crore, while its revenue fell by 4.6% YoY due to a decline in its chemical intermediaries segment revenue. The firm missed Trendlyne’s forecaster estimates for revenue by 2.2% and for net profit by 0.7%. 

    FY24 was a difficult year for the company as well. The firm saw a fall in net profit of 40.5% YoY to Rs 182.9 crore, while the revenue declined by 13.2% YoY due to weaker speciality chemicals and chemical intermediaries segment revenue. While the firm beat the forecaster estimate for revenue in FY24 by 0.9%, hit missed the net profit estimate by 4.4%. The stock shows up in a screener for stocks sold by superstar investors.

    Among the better performers this quarter was the company’s specialty chemicals segment, which constitutes 42% in the revenue mix and grew by 8.3% YoY.  EBIT margin improved to 14.5% from 9.5% in Q4FY24 for this segment. However the chemical intermediaries (acetyl) segment which constitutes 40% of the revenue mix struggled, due to lower demand coming from the paracetamol end-use segment and lower acetic acid prices.

    Deepak Jain, CEO and Managing Director of the firm highlighted that in the CDMO (contract development and manufacturing organizations) space, the company is in “advanced stage discussions” for multiple projects in pharma, agro and semiconductor end-use. He expects CDMO to grow at 25-30% in FY25. He adds that the specialty segment is expected to have an EBITDA of 20%+ in steady state, and with new launches going forward, EBITDA may reach 23-25% in the next 2-3 years.

    Prabhudas Lilladher has maintained its “Hold” rating on Jubilant Ingrevia, with a target price of Rs 592. The brokerage notes that the company has been adding capacities across segments, but challenges are expected to persist due to international pricing pressures and agrochem weakness, which the brokerage expects will only resolve in the later stages of H2FY25.

    4. Just Dial:

    This internet software company hit a new 52-week high of Rs 1,304 on Friday after surging 26.5% in the past week, following the release of its Q1FY25 results. The company’s net profit grew 69.3% YoY to Rs 141.2 crore, surpassing Trendlyne’s Forecaster estimates by 16.5%.This was helped by lower employee benefit expenses and finance costs, and a deferred tax credit of Rs 3.9 crore. EBITDA margins were up by 13.8 percentage points YoY to 28.7%.

    The company has outperformed the internet software industry by 4% over the previous quarter. Just Dial expanded its active business network to 4.5 crore firms during the quarter, and attracted 18.1 crore unique quarterly visitors, with 85.2% accessing the platform via mobile sites and apps.

    Commenting on the company’s target, MD & CEO VSS Mani said, “We are targeting 15-17% revenue growth for FY25 and an EBITDA margin over 25%".  He also highlighted the firm’s plans to launch its B2B offerings via the JD Mart app and expand its presence in Tier 2 and Tier 3 cities.

    ICICI Direct maintains a "Buy" rating on the stock with a target price of Rs 1,210. The brokerage believes that the company’s focus on Tier 2/3 cities, coupled with price hikes and other initiatives, will drive future growth. It expects revenue and PAT to grow at 15% and 18.9% CAGR respectively over FY25-26.

    5. Glenmark Pharmaceuticals:

    This pharma company has risen by 13.7% in the past month and hit its all-time high of Rs 1,427 on Tuesday. In the past week, the company announced its exit from its arm Glenmark Life Sciences through an offer for sale. Glenmark Pharmaceuticals and Managing Director Glenn Mario Saldanha will divest their 7.9% stake (approx 96.1 lakh shares) for Rs 779 crore. In March, the firm also sold a 75% stake in Glenmark Life Sciences to Nirma for Rs 5,651 crore. This step was taken to improve its weak balance sheet and high debt position. After the divestment, the company has turned net cash positive.

    In the past week, the company also received US FDA approval for topiramate capsules, a bioequivalent to Topamax, used in people with epilepsy to treat and prevent seizures. It has annual sales of $21.9 million.

    Trendlyne Forecaster estimates the company’s net profit to grow approx 12X in the upcoming Q1FY25 results. In FY24, the company reported a loss of Rs 1,501.7 crore compared to a profit of Rs 297.2 crore in FY23.

    Going forward, the management expects its global brands like Ryaltris and Salmex to drive growth and become worth $300-400 million over the next five years. It expects Ryaltris’ annual sales to double by FY25 from $40 million currently. Speaking about targets, the management stated, “For FY25, our revenue target is Rs 13,500-14,000 crore (up from Rs 12,653.1 crore in FY24) and EBITDA margin target is close to 19%.” The company plans to spend Rs 700 crore in capex, and around 7% of revenue on R&D.

    KRChoksey maintains a ‘Buy’ call on the stock and expects revenue to grow at a CAGR of  10% and profit at a CAGR of 41.4% over FY25-26. It believes that the company’s domestic segment has a strong growth trajectory, as it has been able to outperform in key therapy areas such as respiratory, derma and cardiac, and it expects its market share to increase. The company appears in a screener for stocks with increasing shareholding by foreign investors and/or institutions.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    19 Jul 2024
    Rising credit is causing investors worry around bank stocks | Screener: Banking stocks with higher prices, healthier NPAs

    Rising credit is causing investors worry around bank stocks | Screener: Banking stocks with higher prices, healthier NPAs

    By Swapnil Karkare

    The Godrej steel almirah, first launched in 1923, came with a sturdy inside locker for storing valuables: jewellery, cash bundles, land deeds, letters from faraway family members. The almirah was just one signifier of a country of savers. Indian households have long been reluctant to take on debt.

    That however, is changing fast. India's household debt has grown steadily, hitting new highs of over 39% of India's GDP in FY24. The biggest growth has been in non-housing loans.

    With household debt rising and and corporate borrowings also up, banks have seen a big shift over the past two years, with their credit growth surpassing deposit growth. While the credit surge in a typically credit-starved country should be celebrated, the falling savings rates and rising household debt are red flags.  

    Banks make money from the difference between the interest they earn on loans, and the interest they pay to depositors. So a rising credit deposit gap should be good news for their profts, right? The reality is more complicated. Let's take a closer look.

    In this week's Analyticks:

    • The credit boom for banks: Is rising credit growth turning into a pain point?
    • Screener: Bank stocks with falling non performing assets

    Are banks getting stressed with high credit growth?

    From April 2022 onwards, banks have seen credit growing at an average rate of 16% YoY, surpassing deposit growth of 11% YoY. The figures exclude the merger of HDFC Ltd. with HDFC Bank.

    Credit growth has even outpaced India's nominal GDP growth rate for 7 consecutive quarters. In the June monetary policy statement, RBI governor Shaktikanta Das said that bank management should try to address this persisting gap.

    RBI’s Financial Stability Report (FSR) cautioned that credit growth beyond current levels may not be sustainable. As of 28th June 2024, credit growth slowed to 14% while deposit growth was at 11%. RBI's previous analysis showed that these high-credit cycles usually last for 41 months on average.

    Banks’ provisional data and estimates from brokers also suggest that the unwinding of credit growth may have begun from Q1 FY25. But the credit-deposit gap still persists, and public sector banks in particular have been struggling with deposit growth.

    Walking the tightrope

    The credit-to-deposit (CD ratio) tells us how much money banks have lent out, compared to their deposits. A very low ratio means banks are not lending enough, while too high a ratio could mean that banks have few liquid assets (deposits) left.

    The problem with a too-high ratio is also that if depositors suddenly withdraw their funds in large amounts, banks may face liquidity challenges, making it difficult to meet short-term obligations. It's a tightrope that banks need to walk.

    The tolerable or 'normal' range for the CD ratio is around 80%. RBI does not prescribe any ideal level. The ratio has been in general, lower for public sector banks indicating better asset-liability management systems, compared to their private counterparts.

    The incremental CD ratio - the ratio of additional credit and deposits over a particular period - crossed 100% in FY24, raising eyebrows. While public sector banks have been able to bring it down, private sector banks have pushed it even higher. This indicates aggressive lending techniques in the private sector, and the merger’s impact on HDFC Bank. 

    Some banks in the public sector have started raising the term deposit rates they offer to attract depositers. But private banks, on average, have reduced these rates as per the latest available data.

    Margins are likely to see a hit if banks are pushing deposit rates higher without changing their lending rates. Brokers estimate that bank net interest margins will take a hit of 10-15 bps in Q1FY25. Although public sector banks fare better in most parameters, NIM compression as they raise deposit rates will hit their profitability.

    Right now, public sector banks are at the top 

    It is banks with lower CD ratios, higher liquidity coverage (LCR), good fundamentals (higher Durability score) and appropriate valuations (higher Valuation score) will be able to sail through volatile times ahead. 

    Our analysis finds public-sector banks such as Bank of Maharashtra and Karur Vysya Bank are in better shape than the private sector. State Bank of India and ICICI Bank, also have a good trajectory.

    1. Bank of Maharashtra:

    The bank’s credit growth has been remarkable at 3% QoQ during the quarter ending June 2024. With an ROE of more than 20%, a healthy CD ratio and liquidity (LCR), and favourable Trendlyne scores, BoM emerges as a strong performer compared to its peers. 

    1. Karur Vysya Bank:

    A bank that has maintained an LCR of more than 200% for a long time is worth adding to the watchlist. A recent ICICI Securities report highlighted that it has the lowest cost of deposit and net NPAs, compared to its peers. Provisional data for the quarter ended June 2024 showed a 4% QoQ increase in loans and deposits, one of the highest amongst peers. 

    Risks are rising, favouring the most cautious bank players

    A strong economic outlook, a possible interest rate cut and a good monsoon all point to a booming bank sector. However, we cannot ignore a key risk: rising credit.

    Considering over-leveraged households, weak consumption growth and weak rural incomes, the RBI has been taking actions to safeguard the banking system. But risks like seasonal slippages in the agricultural and microfinance sectors, lower recoveries, and NIM compression will haunt banks for at least a couple of quarters.

    In such times, investors need to be cautious. Any one or a combination of these factors can shake up the sector. 


    Screener: Banking stocks rising over the past quarter with falling NPAs in Q4FY24

    PSU and small finance banks see a decline in gross NPAs

    With the start of the Q1FY25 results season, we take a look at banks and financial institutions that saw a fall in their non-performing assets (NPAs) YoY in Q4FY24. This screener shows banking and finance companies that rose over the past quarter with a YoY decrease in gross and net non-performing assets (NPAs) in Q4FY24.

    The screener primarily consists of PSU and small finance banks. Major stocks that appear in the screener are Jana Small Finance Bank, Federal Bank, Indian Bank, Bank of Maharashtra, Bandhan Bank, Yes Bank, Punjab & Sind Bank and Central Bank of India.

    Jana Small Finance Bank has surged 58.1% in the past quarter. Its gross NPAs contracted by 180 bps YoY to 2.1% in Q4FY24, while its net NPAs fell by 208 bps YoY to 0.6% during the quarter. This helped the bank’s provisions to decline by 12.1% YoY to Rs 175.4 crore. The decline in NPAs was helped by a low gross NPA of 0.3% in the affordable housing segment which contributes to 18% of the bank’s total advances. Systematix expects the company’s deposits to grow on the back of its strategy to relocate branches to areas with potential for higher deposits. 

    Indian Bank has risen 14.6% over the past quarter on the back of strong Q4FY24 results. Its gross NPAs declined by 200 bps YoY to 4% in Q1FY24, net NPAs also contracted by 47 bs YoY to 0.4% due to a moderation in slippages and a reduction in booking loans. This decline in gross and net NPAs helped the bank’s provisions to reduce by 51.3% to Rs 1,247.8 crore during the quarter. According to ICICI Direct, the company’s focus on improving asset quality, stable margins, healthy fee income, and low operational expenses will help sustain its performance.

    You can find more screeners here.

    1
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    18 Jul 2024
    Five stocks to buy from analysts this week - July 18, 2024

    Five stocks to buy from analysts this week - July 18, 2024

    By Ruchir Sankhla

    1. Varun Beverages:

    Motilal Oswal reiterates a ‘Buy’ rating on this non-alcoholic beverages company with a target price of Rs 1,900, indicating a potential upside of 18.8%. Analysts Sumant Kumar, Meet Jain and Omkar Shintre highlight the company's new exclusive snacks deal with PepsiCo for Zimbabwe and Zambia. VBL plans to invest $7 million each in these countries to build snack manufacturing plants capable of producing around 5,000 metric tons annually, with production starting by October 2025 and April 2026, respectively.

    The analysts note that the total addressable market (TAM) has expanded by 67% with the addition of these two new geographies (versusMorocco earlier in Feb 2024). They highlight the snack food products market in these regions is valued at approximately $833 million as of CY24.

    Kumar, Jain, and Shintre expect a CAGR of 21% in revenue, 22% in EBITDA, and 29% in PAT for CY25-26. They also foresee a potential partnership between VBL and PepsiCo across Africa, where PepsiCo lacks local manufacturing partners and relies on imports.

    2. Sky Gold:

    Edelweiss maintains a ‘Buy’ rating on this gems & jewellery smallcap company with a target price of Rs 3,204, indicating a potential upside of 68.9%. Sky Gold recently acquired Sparkling Chains for Rs 26 crore, a chain manufacturer accounting for 20% of India's jewellery sales, and Starmangalsutra for Rs 24 crore, which holds a 15% market share in the mangalsutra segment.

    Analyst Palash Kawale writes, "These acquisitions will expand Sky Gold’s market in gold jewellery and diversify its product range." Sky Gold's addressable market share in India's jewellery sales has increased to 70%, up from 35%. The analyst also highlights that the management expects the acquired entities to generate sales of more than Rs 600 crore in FY25 and a PAT of more than 15 crore in FY25.

    Kawale expects revenue, EBITDA, and PAT to increase by 53%, 56%, and 67%, respectively over FY25–27 and says, “Sky Gold can be a long-term compounding story.” He also mentioned that following these acquisitions, the management has upgraded its FY27 sales guidance to Rs 6,300 crore with over 25% RoCE.

    3. National Aluminium Company:

    SBI Securities initiates a ‘Buy’ rating on this aluminium and aluminium products company with a target price of Rs 234.6, indicating a potential upside of 22%. Analysts highlight significant developments, including NALCO's acquisition of a mining lease for bauxite mines in Odisha and a strategic MoU with NTPC for uninterrupted 1200 MW power supply. These developments are essential for NALCO's plans to expand the smelter plant capacity in Angul, Odisha.

    Analysts note that in FY24, NALCO successfully increased production at its Utkal coal mine to 2 million tonnes per annum (mtpa), resulting in significant reductions in power and fuel costs. The upcoming Utkal Block E expansion to 4 mtpa by FY25 is expected to further enhance cost efficiencies. The brownfield alumina expansion, targeting 1 mtpa, remains on track for commissioning by the second half of FY26, with full production expected to be achieved by FY27, promising expanded revenue streams. Additionally, NALCO plans to expand its aluminum smelter capacity by 0.5 mtpa in the coming years to strengthen operational capabilities.

    4. Tata Consultancy Services:

    Sharekhan maintains its ‘Buy’ call on this IT consulting and software company with a target price of Rs 4,750, indicating a potential upside of 11.2%. The company’s revenue grew 5.4% YoY to Rs 62,613 crore in Q1FY25, and its net profit rose 8.7% YoY to Rs 12,040 crore, driven by outperformance in manufacturing, energy and healthcare segments.

    Tata Consultancy Services plans to expand its digital transformation services and enhance its AI capabilities. The company has established new client partnerships and expects spending on tech modernizing systems to grow. Analysts are upbeat, saying that the company is working to mitigate risks from currency fluctuations and an uncertain global economy by diversifying across markets and investing in technology and talent. The management highlights consistent order bookings of Rs 700-900 crore quarterly, with an all-time high pipeline in Q1, as AI investments doubles to Rs 150 crore.

    Sharekhan anticipates TCS to sustain growth despite margin pressure from wage hikes. The firm projects a robust revenue CAGR of 11% and an adjusted PAT CAGR of 15% for FY25-26, buoyed by substantial deal wins and a healthy order pipeline.

    5. Indian Bank:

    ICICI Direct maintains a ‘Buy’ rating on this bank, raising its target price to Rs 700, indicating a potential upside of 21.6%. This PSU bank has a total business of over Rs 12 lakh crore and a strong presence with 5,847 branches nationwide.

    The bank is focused on enhancing its retail, agriculture, and MSME loan segments, which constitute about 62% of its loan book. It aims to maintain a steady CASA ratio of around 40% and expects margins to remain stable at 3.4-3.5% for FY25. Analysts Vishal Narnolia and Krishna Vyas have a positive outlook on the bank as it pursues digital transformation initiatives to improve customer experience and operational efficiency. It targets a 12-13% growth in advances for FY25, supported by new business opportunities in data centres, city gas distribution, and commercial real estate sectors.

    Narnolia and Vyas anticipate that the company will achieve a CAGR growth rate of 11% for net interest income and 18% for PAT over FY25-26. They expect Indian Bank to see steady business growth and strong asset quality, projecting an improvement in RoA to 1.2-1.3% by FY25-26.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    16 Jul 2024, 06:20PM

    Chart of the Week: DVM screener delivers CAGR of 38% over 11 years

    By Satyam Kumar

    Investors are always on the lookout for strategies that yield outsize returns, yet the reality is that only a select few manage portfolios that consistently outperform their benchmarks. Legendary investor Warren Buffett once said, "The stock market is designed to transfer money from the active to the patient." Despite the temptation to trade often, its the  long-term perspective that delivers returns, and this calls for a disciplined approach in navigating stocks.

    One way to maximise returns is by using screeners that automatically search for stocks that outperform on not one or two but multiple metrics. The DVM score for example, looks at several metrics across management quality, financial health, stock valuation, as well as several dozen technicals, to identify high-scoring stocks. These scores help investors shortlist quality stocks for investing.

    In this edition of Chart of the Week, we analyse one particular DVM screener: the ‘DVM - High Performing, Highly Durable Companies’ screener. This screener selects stocks from the Nifty 500 index that have strong financial durability, reasonable valuation, and positive momentum scores. It is optimised to highlight the top five stocks with the highest durability scores. 

    The screener backtest, which ran from March 2013 to June 2024, evaluated this strategy’s quarterly performance against the Nifty 500 benchmark. The screener delivered cumulative returns of 3,676.3% over 11 years and 4 months, with a CAGR of 37.7%. In contrast, the benchmark’s CAGR stands at 16.1%. The portfolio review frequency chosen for this backtest is quarterly.

    The heatmap presents a period analysis, showcasing the strategy's quarterly returns from Q1FY14 to Q1FY25. The data reveals that this approach delivered positive returns in 31 out of 45 quarters. It also outperformed the Nifty 500 index in 29 of these 45 quarters. 

    The strategy experienced a maximum drawdown of 28.4% in Q1FY23. The term "maximum drawdown" represents the largest observed loss from a portfolio’s peak to its lowest point before a new peak is attained. This strategy is automated and did not have a set stop loss, so the drawdowns show the maximum loss potential under this approach. Introducing a stop loss can reduce periods of negative returns and lower maximum drawdowns.

    The screener currently has stocks such as Bombay Burmah Trading Corporation, Adani Ports & Special Economic Zone, Jindal Saw, Ambuja Cements, and Apollo Tyres.

    In the course of the backtest,Ceat gave the highest returns of 428.8%. On the other hand,Triveni Engineering & Industries’ stock price had the highest fall of 48.8%.  

    Apar Industries and EIH performs the best in the DVM screener over the past two years

    Here, we look at stocks with the highest returns over the past two years from the DVM screener’s backtest. Electrical equipments maker Apar Industries was part of the screener from March 31, 2023, to June 28, 2024. During this period, it delivered a return of 238.3%.

    Similarly, EIH, a hotel company belonging to the Oberoi Group, was active in the screener a quarter ago from December 29, 2023, to March 28, 2024. In these three months, the company gave a return of 80.2%.  The jump came as the hotel stock saw its financials improve as domestic tourism boomed. In FY24, EIH witnessed a  103% YoY rise in its net profit to Rs 639 crore, aided by growth in the luxury hotel segment, which boosted average room rates.

    Great Eastern Shipping Company, which provides shipping and offshore business services to primarily oil & gas companies, was active in the screener for a year. The stock delivered returns of 65% during the period starting June 30, 2023, to June 28, 2024.

    The tobacco major, Godfrey Phillips remained in the screener for two quarters, from September 30, 2022, to March 31, 2023. During this period, the company gave 58.5% returns. The company's decision in October 2022 to sell its chewing tobacco business and other trademarks allowed it to concentrate on the cigarette business. Consequently, its net profit surged by 57.6% YoY in FY23 to Rs 690.5 crore.

    Lastly, Kalyan Jewellers India, active in the screener from June 30, 2023, to September 29, 2023, delivered a return of 46.7%. The rise came after the company’s net profit surged by 33.3% in Q1FY24 to Rs 143.9 crore, aided by expansions in northern regions of India and the UAE.

    Adani Ports leads in one-year gain among active stocks

    Let’s now focus on the quarterly and yearly price change percentages of stocks currently active in the screener. Packaged foods company Bombay Burmah Trading Corporation’s stock price rose by 46.2% in the past quarter and 104.3% in the past year. The company’s net profit increased by 189.6% YoY in Q3FY24, followed by a surge of 116.1% in Q4FY24.

    Marine port & services company, Adani Ports & SEZ witnessed its share price surge by 14% in the past quarter and 106.5% in the past year. The company delivered a volume CAGR of 15% over FY19-24 outperforming volume CAGR of 4% for all ports in India.

    Meanwhile, industrial products manufacturerJindal Saw’s share price soared by 13.7% in the past quarter with gains of 78.4% in the past year. Ambuja Cement, on the other hand, witnessed a 12.9% uptick in its stock price in the past quarter and 64.5% in the past year.

    Lastly, Apollo Tyres saw its share price surge by 16.3% in the past quarter, with over 32.4% gains in the past year. In FY24, this tyre manufacturer brought down its debt significantly by Rs 1,646 crore to Rs 3,942 crore due to 61.2% higher cash from operations on a YoY basis.

    In summary, the screening criteria results in stocks that can potentially deliver medium to long-term gains with moderate risk, as suggested by the max drawdown of 29.9%. Despite uncertainties like the Covid pandemic and highly volatile election periods, this screener gave a mean quarterly return of 9.7%. It also consistently held an average stock count of 4.7, implying diversified investment, except for Q1FY21 when it had no stocks.

    4
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    12 Jul 2024
    Five Interesting Stocks Today - July 12, 2024

    Five Interesting Stocks Today - July 12, 2024

    1. Rail Vikas Nigam (RVNL):

    This railway construction firm surged to a new 52-week high of Rs 645 on Friday after rising 49.7% in the past week. RVNL is engaged in the complete life cycle of projects in railway track construction, railway electrification, and signalling solutions. The surge followed the company's receipt of a LoA from Maharashtra Metro Rail Corp. for the construction of six new elevated metro stations in Nagpur, worth Rs 187.3 crore. The company also emerged as the lowest bidder for a South Eastern Railway contract worth Rs 202.9 crore. 

    All major railway stocks, IRFC, RVNL, and IRCON International, have risen sharply in the past week after Railway Minister Ashwini Vaishnaw announced plans to introduce 2,500 new general passenger coaches and 10,000 non-AC coaches. He also announced the production of fifty new Amrit Bharat trains, known for their high-speed and luxury services. RVNL stands to benefit from these plans as it is involved in the construction and maintenance of coach manufacturing factories.

    RVNL reported an 8.4% YoY revenue growth to Rs 23,075 crore in FY24, with net profit increasing by 10.8% YoY to Rs 1,574 crore. The company’s order book at the end of FY24 stood at Rs 85,000 crore, with around 40-45% coming from bidding orders, which have margins higher than 10%, while the rest is from nomination projects.

    Director of Operations, Rajesh Prasad, said, “The India-Middle East-Europe Economic Corridor announced in the G20 summit has got big opportunities for RVNL basically in the railway segment.” He highlights that the project is still in the concept stage and RVNL is certainly going to benefit when execution starts.

    IDBI Capital maintains a ‘Hold’ rating on RVNL as the company plans bids for high-speed rail projects under the Viksit Bharat 2047 scheme (currently, they have no exposure to this segment). The brokerage is optimistic given the company’s guidance for net profit growth of 10-15% in FY25, and its focus on improving EBITDA margins by targeting bidding projects.

    2. NBCC (India):

    This construction and engineering company has risen 20.9% in the past month and hit its all-time high of Rs 198.3 on Tuesday. The surge came after the company secured multiple orders worth Rs 1,120.3 crore, including major projects in urban development, educational institutions, and infrastructure.

    NBCC witnessed strong growth in FY24, with a 50.6% YoY increase in net profit to Rs 401.6 crore and a 19% rise in revenue to Rs 10,666.7 crore. This was driven by growth in its project management consultancy (PMC) and engineering, procurement & construction (EPC) segments. The company has underperformed the booming construction industry by 321.8% over the past five years, despite rising by 246%. NBCC aims to overcome this by focusing on redevelopment and real estate sectors.

    The company plans to sustain growth momentum by focusing on its order book, and expects to secure Rs 25,000 crore in new orders in FY25 across housing, railway, metro, and renewable energy sectors. The company holds a current under-execution order book of Rs 20,000 crore and intends to tender projects worth Rs 15,000 crore, aiming to achieve Rs 13,000 crore in revenue for FY25.

    Commenting on the new orders, Chairman and MD, K. P. Mahadeva Swamysaid, "We have won a record new business worth Rs 23,500 crore, which is more than 250% of the previous year. Our order book stands at Rs 64,900 crore, and we expect to achieve a top line of Rs 12,350 - 13,000 crore in FY25, driven by our focus on real estate and infrastructure projects."

    Geojit BNP Paribas has upgraded the stock to a ‘Hold’ rating from ‘Sell’, with a target price of Rs 176. The brokerage expects FY25 and FY26 EPS to rise by 10% and 6%, respectively, driven by robust tendering and execution. However, the firm is in the PE Sell Zone, currently trading above its historical PE.

    3. Tata Elxsi:

    This IT software & services company fell over 2.2% on Thursday as its net profit declined by 6.5% QoQ (-2.5% YoY) to Rs 184.1 crore in Q1FY25, missing Forecaster estimates by 6.3%. The fall was due to higher employee benefits expenses and raw material costs. In addition, EBITDA margins contracted 160 bps QoQ to 27.2% during the quarter. However, on Friday, the stock recovered its previous day’s losses and was up 1.6%, with the broader IT industry rising 4.9% on the back of positive results by heavyweight TCS. 

    Tata Elxsi’s revenue grew by 2.3% QoQ (9% YoY) to Rs 926.5 crore, due to growth in the software development & services or SDS segment, which contributes 97% of the total revenue. The SDS segment consists of transportation, media & communication, and healthcare verticals. 

    During the quarter, the transportation vertical’s revenue grew 5.3% QoQ driven by deal wins, while that of the media vertical rose marginally by 0.5% QoQ. Meanwhile, the healthcare vertical remained muted, as its revenue fell by 4.3% QoQ.  This was due to delayed renewals of some projects by a large US client.

    Commenting on the outlook, CEO & MD Manoj Raghavan said, “We expect continued growth in the transportation segment, led by a strong deal pipeline, particularly in the OEM space”. He sees green shots in the media & communication vertical and highlights the company’s M&A plans going ahead. For FY25, Raghavan projects EBITDA margins in the range of 28-29%.

    JPMorgan retains its ‘Underweight’ call on Tata Elxsi, with a price target of Rs 5,800. It believes the positive surprise in the transport vertical will be offset by headwinds persisting in the healthcare business. The brokerage cuts its earnings estimate by 2-4% over FY25-27 due to higher tax rates. The company is in the PE Sell Zone, indicating it is currently trading above its historical PE.

    4. Indigo Paints:

    This paints company rose by 10.2% over the past week as major industry players, Asian Paints and Berger Paints are expected to hike prices by 0.7-1%. Nuvama stated that the price increase is a proactive measure to compete against Birla Opus, a newcomer, and maintain healthy profit margins. For FY24, the company’s net profit increased by 11.7% YoY to Rs 147.3 crore, while its revenue rose by 21.7% YoY. The stock shows up in a screener for stocks with strong momentum.

    In the past five years, the company’s revenue grew by 20% CAGR, the highest among its peers. It currently ranks as the fifth-largest producer of decorative paints in the country. Recently, it acquired a 51% stake in Apple Chemie India (ACIL) to enter the Waterproofing and Construction Chemicals (WPCC) segment whose FY24 market size was expected to be Rs 20,105.6 crore with a CAGR growth of 13.9% over 2025-33.

    The company also launched a new water-based paint facility in Tamil Nadu and is expanding its capacities for both solvent-based and water-based paints in Rajasthan. The company currently operates five manufacturing units and its production volumes have risen in key segments like cement paints and putty.

    Analysts expect the Indian paint industry to grow at a CAGR of ~12.7% from FY25 to FY27, reaching a market size of ~Rs 1 lakh crore. They highlight that the frequency of home repainting has improved, from every 7-8 years in FY13 to 4-5 years in FY23, indicating a growing paint consumption trend in India. Additionally, the Indian government has raised its infrastructure budget by 11% for FY25. These factors are expected to be key growth catalysts for the company.

    Keynote Capital has given Indigo Paints a “Buy” rating, with a target price of Rs 1,594. The brokerage notes that the company has consistently achieved growth rates of 2-2.5X compared to its peers. We expect IPL to grow its revenue by 18% in FY25 and, due to operating leverage, expect margin to improve further.

    5. Zydus Lifesciences:

    This pharma company rose by 3.4% in the past week and hit an all-time high of Rs 1,203 on Thursday. The company also appears in a screener for stocks outperforming their respective industry over the last quarter.

    The price rise followed multiple approvals by the US FDA. The firm won approval for Sacubitril and Valsartan, used to treat chronic heart failure. These tablets have annual sales of $5.5 billion. In the past week, it also received US FDA approval to market diroximel fumarate delayed-release capsules, a treatment for multiple sclerosis, which has annual sales of $847.4 million. 

    Zydus Lifesciences has been busy over the past month – it received approval for azilsartan, indicated for the treatment of hypertension to lower blood pressure. Azilsartan has annual sales of $89 million. Zydus and Dr. Reddy's Laboratories also announced a licensing agreement for the co-marketing of a pertuzumab biosimilar, a critical treatment for breast cancer patients in India.

    Trendlyne Forecaster estimates Zydus Lifesciences’ net profit to rise 5.5% YoY in Q1FY25. In FY24, the company’s profit grew by 102.3% YoY to Rs 3,972.8 crore, while its revenue improved by 13.8% YoY. It also beat Trendlyne Forecaster’s net profit estimate by 7.8%. Speaking about the growth outlook, Managing Director Sharvil Patel says, “We expect all our businesses to register high-teen growth. We also expect to comfortably maintain FY24 margins of 27.5% in the coming year, and we will do our best to improve those margins.”

    Geojit BNP Paribas is positive about Zydus Lifesciences due to new drug launches and its existing portfolio. However, the brokerage states that the company’s valuations are looking expensive. The firm is trading in the PE Sell Zone.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    11 Jul 2024
    The big winners: Five stocks expected to top the Q1FY25 results season | Screener: Stocks with upcoming results and rising share prices

    The big winners: Five stocks expected to top the Q1FY25 results season | Screener: Stocks with upcoming results and rising share prices

    By Tejas MD

    It’s a great time to be a stock market investor. The benchmark Nifty 50 is up 11.7% post election, and has risen 26.4% in the past year. In fact, between June 25 and July 4, records fell left and right as the Nifty hit its lifetime high in every single trading session and closed in the green for a fifth straight week. 

    So right now, most investors are looking at their portfolios and feeling like geniuses. Over 50% of Nifty500 stocks are near their 52 week highs. In this bull market, losers are few. But how long will the party last?

    Analysts are divided on this. While some think this is the best time to invest in the Indian stock market, many are skeptical. 

    Kotak Securities expects Nifty 50 companies’ Q1FY25 profit to be flat YoY and decline 10.7% QoQ. Downbeat Q1 results could lead to a correction in a stock market many already find too hot, according to Bloomberg. 

    The results season will dictate the market direction, alongside the Union budget on July 23. We take a look at five growth stocks that are expected to stand out from the pack. 

    In this week’s Analyticks, 

    • Q1FY25 pre-results special: Five companies set to zoom with high growth, even in a weak results season
    • Screener: Upcoming results for Nifty500 stocks which delivered 10%+ revenue and profit growth in FY24

    The big winners: Five stocks expected to top the Q1FY25 results season

    Analysts have been picking their favourite stocks ahead of the Q1FY25 results. Among these, we shortlisted five Nifty 500 companies that are predicted to post especially high revenue and net profit growth both YoY and QoQ in the June quarter, according to Trendlyne’s Forecaster. What’s more? These companies already set the bar high with strong results in Q4FY24.

    Growth stocks in focus are from five different industries

    All five stocks in focus, Apollo Hospitals Enterprise (AHEL), Natco Pharma, Varun Beverages (VBL), KPIT Technologies, and Bajaj Auto are from different industries. 

    Except for Apollo Hospitals, all stocks have risen sharply over the past year, and have also outperformed the Nifty 50.

    Only Apollo Hospitals lags Nifty 50 in the past year

    As a result of the upswing, the Trendlyne Momentum scores for these companies range from neutral to high, indicating buying interest in the market. However, low Valuation scores for Apollo Hospitals, Varun Beverages and KPIT Tech are a sign that they may be expensively priced. 

    Natco Pharma top of the five, with good Durability, Valuation and Momentum scores

    These companies also have high durability scores, thanks to strong financials and management stability. 

    AHEL’s hospitals and labs to drive growth, but expensive valuation raises concerns 

    Apollo Hospitals, the first hospital to be included in the Nifty 50 index, is expected to see a sharp rise in revenue (+54.6%) and net profit (139.7%) YoY in Q1FY25. 

    Apollo Hospital’s revenue to grow both YoY and QoQ in Q1FY25

    Healthcare services like hospitals, and diagnostics & retail health segments are expected to increase margins and drive revenue. The company’s digital business, which includes Apollo 24x7, is still spending more than it earns, and is expected to breakeven in the next six to eight quarters. 

    Apollo’s competitive advantage lies in its omnichannel brand presence: it's no longer just a hospital. From clinics, hospitals and diagnostics to pharmacies (online and offline), vertical integration is helping the company to acquire customers from one business unit to another. 

    Analysts are positive about the company as it is adding new beds, increasing high-margin surgeries, and broadening its test menu in the diagnostics segment.  

    However, analysts believe the hospital’s recent fundraising of Rs 2,475 crore through private equity firm Advent International for its Apollo 24/7 was lower than expected. When the fundraising announcement came out on April 29, the stock fell 8% intraday. But the share price has recovered since, as investors look ahead to its Q1FY25 results. With high profits expected, the company’s PE is also elevated at 103 but is in the neutral zone according to its historical averages.

    Landmark anti-cancer drug boosts Natco Pharma, generic weight loss drugs in the pipeline

    This pharma company is a specialist in complex generic products, with a focus on high-risk, high-reward drug launches in the US. Natco's export formulations make up 81% of its total revenue. This segment grew 35% in Q4FY24, mainly due to its anti-cancer drug gRevlimid.

    Analysts expect these gains to continue in Q1FY25, and for a few more quarters. The stock has a PE of 15.6 and is in the PE Strong Buy Zone indicating that it is currently trading far below its historical PE.

    gRevlimid sales to drive Natco Pharma’s topline in Q1FY25 

    To offset slowing sales from Revlimid down the line, the management plans to launch 6-7 more niche products. Drugs in the pipeline include generic Ozempic and Wegovy - the blockbuster weight loss and antidiabetic drugs - and gLynparza (anti-cancer). Natco is also banking on new first-to-file (FTF) opportunities as other companies' drug patents expire.  

    The company is also focusing on acquisitions in emerging markets. The management plans to use its cash in hand (Rs 2,004 crore available) to fund acquisitions. Rajeev Nannapaneni, CEO of Natco Pharma said, “Emerging markets give you more broad-based earnings, and consistent earnings. Acquisition there is the way to go. Acquisitions in India in comparison, are very expensive.” 

    Varun Beverages continues its momentum, expansion in Africa set to be the next growth driver

    Varun Beverages is the largest bottler of PepsiCo's beverages globally, outside the US. This company’s share price has nearly doubled in the past year and has jumped by 6.7X in the last three years. VBL’s revenue and net profit are expected to rise by 31.8% and 34.1% YoY in Q1FY25. However, the company is in the PE Sell Zone indicating that it is currently pretty expensive and trading above its historical PE. 

    Lower input prices drive margin higher in Q4FY24

    Varun Bev plans to increase its international revenue (20% of its sales volume now) and is expanding its footprint in Africa through capacity expansions, acquisitions and licensing rights from PepsiCo. In the Q4FY24 earnings call, Ravi Jaipuria, VBL’s Chairman, mentioned that the Africa business unit is expected to be a major growth engine in revenue and profitability. 

    But a growing threat for the company is its rival Coca-Cola's plan to sell a part of its bottling business, Hindustan Coca-Cola Beverages (HCCB). Coca Cola is eyeing an investment of about US$ 800 m to US$ 1 billion in a bid to grow its business and capture market share in India.

    Demand for EVs and passenger vehicles fuels KPIT Tech’s growth

    ThisIT software company hasrisen by an impressive 61.6% in the past year, outperforming theNifty IT by 24.5 percentage points.KPIT Technologies provides engineering solutions for firms in  the booming CASE (Connected Autonomous Shared and Electric) auto segment. KPIT Tech’s revenue and net profit areexpected to rise both YoY and QoQ in Q1FY25.

    However, the company is in the PE Sell Zone and is currently trading above its historical PE. 

    Rising EV demand to help KPIT Tech’s topline growth

    For FY25, the revenue growth guidance for the IT sector overall is weak. Tier-1 companies are expected to post low single-digit growth, and Tier-2 high-single-digit growth. But KPIT Tech is expected to see 22.4% revenue growth in FY25.  

    S.B. Ravi Pandit, Co-Founder and Chairman believes that the outperformance is due to the company’s focus on the mobility industry. 

    The growth in the mobility & autonomous space is driving revenue for KPIT. Feature development and integration for auto bodies and auto electronics was the fastest-growing segment for KPIT in Q4FY24, with a rise of 29.4% YoY. This segment contributes to 62% of the total revenue. The company plans to build more domain expertise by adding more capabilities through joint ventures and acquisitions.

    Analysts expect Bajaj Auto’s exports to rebound, add to topline growth

    The auto & auto components sector has had a pretty good year, with the sector rising 76.6%. But Bajaj Auto has outperformed its sector, and risen 105.9% over the same period. Despite this rise, the TTM PE ratio of this stock (34.5) is lower than its industry average of 39.4. 

    Domestic sales have outshone exports in the past year for Bajaj Auto. The 125+ cc segment, which contributes to 75% of the domestic revenue, drove revenue growth on the back of new product launches. 

    Overall sales are up, despite muted exports. The company’s export volumes in FY24 were at 65% of the peak seen in FY22. However, analysts expect export markets to recover from the macroeconomic issues they faced in the last two years. This gives Bajaj a lot of room to grow.

    Analysts expect Bajaj Auto’s exports to recover in Q1FY25

    Analysts also expect growth from domestic premiumisation and export recovery within 3-Wheelers (3W) as the company expands its footprint in CNG 3W and e-autos. 


    Screener: Upcoming results for Nifty500 companies which delivered strong FY24 net profit and revenue growth

    Finance and IT stocks rise ahead of Q1 results

    As the results season starts, we take a look at rising stocks which already saw high growth in net profit and revenue for FY24. This screener shows companies whose share prices are rising as results come up, and with over 10% net profit and revenue growth in FY24. 

    The screener is dominated by stocks from the asset management, banking, NBFC and IT consulting & services industries. Major companies that feature in the screener are Persistent Systems, Elecon Engineering, HDFC Life Insurance, HDFC Asset Management, Crisil, L&T Technology Services, Anand Rathi, and Havells India.

    Persistent Systems has risen 20.4% over the past month. This IT software & services company’s net profit increased by 18.7% YoY to Rs 1093.5 crore in FY24, driven by improved sales, strong product development, and a well-balanced portfolio mix in the healthcare and BFSI segments. KR Choksey believes that the company’s financial performance will continue to beat its larger IT peers, but may witness a relative slowdown in FY25. Trendlyne’s Forecaster expects its net profit to grow by 32.4% YoY in Q1FY25.

    HDFC Life Insurance has risen by 10.9% over the past month ahead of its results, scheduled to be released on July 15. This life insurance company’s net profit grew by 15% YoY to Rs 1,574.1 crore in FY24 due to a higher-than-expected boost in its unit-linked insurance plans (ULIPs). Geojit BNP Paribas expects the company’s cross-selling with HDFC Bank to grow; its reach in tier 2 & 3 cities is also set to improve. Trendyne’s Forecaster estimates its net profit to grow by 25.2% YoY in Q1FY25. 

    You can find more screeners here.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    10 Jul 2024
    Chart of the Week: Current market breadth indicates bullish momentum for the Nifty500

    Chart of the Week: Current market breadth indicates bullish momentum for the Nifty500

    By Satyam Kumar

    Nifty500 recently crossed the landmark 23,000 level, as it witnessed a swift rally rising 13.5% post-elections. 

    How broad-based is the momentum right now?  In the June quarter, 234 of the 500 stocks in the index were trading at a discount of more than 10% from their 52-week highs, which means that more than 50% of Nifty500 stocks were hovering near year highs, a bullish signal. 

    Analysing data from the past five years, we see that the Nifty500 is more likely to hit new highs when more than 50% of its stocks are trading near their year highs.

    In this week’s Chart of the Week, we take a look at the number of Nifty500 stocks trading at a discount of over 10% from their 52-week highs, for every quarter over the past five years. We try to identify the correlation between overall market sentiment and the performance of Nifty500.

    This screener tracks all Nifty500 stocks trading at a discount of more than 10% from their 52-week highs. Here, the screener rewind feature came in handy as it helped us to go back in time and see the number of stocks that were trading at a discount in previous quarters. 

    Markets witness a roller coaster ride during the pandemic

    On March 12, 2020, Nifty500 saw a decline of over 8% as Karnataka confirmed its first death from the Covid pandemic. The market also took a hit as the World Health Organization (WHO) declared the COVID-19 outbreak a global pandemic. In the weeks following up to March 12, the index had already set foot on a steady descent, declining more than 20% as Covid cases rose across the country.

    Two weeks later, on March 23, Nifty500 crashed by another 917 points after falling 12.8% in a single day. The next day, PM Modi called for a complete lockdown as the death toll in India reached 10 and over 14,000 globally. Looking back in time, we can see that the lockdown imposed from March 24 eventually turned out to be a positive one for the stock market. Nifty500 also found the floor of what seemed like a bottomless pit at 6,151.6. 

    Low interest rate period post-pandemic boost market to new highs 

    Even though the lockdown seemed like a necessary caution to contain the spread of the deadly virus, it led to another set of tensions—an economic slowdown globally which led to many people losing their jobs. With everything at a standstill, consumption plummeted, and businesses began to fail. By the end of Q4FY20, the number of Nifty500 stocks trading at a discount of more than 10% jumped to 400, up from 281 stocks a quarter earlier.

    To counter this, central banks worldwide slashed interest rates to negligible levels, injecting money into the economy to spur growth. The Reserve Bank of India (RBI) reduced its repo rate to 4% in May ‘22, and the US Fed slashed interest rates to 0.25% in March ‘22. This led to rampant borrowing and growth among major economies, causing most stocks to rally to all-time highs. Nifty500 rallied from a pandemic low of 6,151.6 to a high of 16,004.5 in just over a year and a half.

    Low borrowing costs worldwide boost the economy, but send inflation sky-high

    But, just as the world came out of the pandemic, another problem arose. Rising inflation started hitting both consumers and businesses. In Q3FY22, 364 Nifty500 stocks traded at a discount of more than 10%, which is a significant jump compared to 247 stocks a quarter ago.

    In a bid to control inflation, central banks started raising interest rates. As a result, most of the companies, now used to low pandemic-era rates, were hit by rising financial costs on their bottom line. In the chart above, it is clear that the market sentiment remained bearish for six consecutive quarters starting from Q3FY22 to Q4FY23. During this period, more than 70% of the stocks belonging to the Nifty500 index traded at a discount of more than 10% from their annual highs.

    The bearish trend came to a halt as RBI surprised markets by holding interest rates steady at 6.5% on April 6 following six consecutive hikes. Most analysts had expected one final 25 basis point (bps) hike in the RBI's current tightening cycle, which has seen it raise the repo rate by a total of 250 bps since May last year. 

    As soon as rate hikes stopped, and speculations surrounding rate cuts started to emerge, Nifty500 witnessed a swift rally to break the 16,000 mark on June 7 last year. In Q1FY24, there is a significant decline in the number of stocks that are trading at a discount of more than 10% from their one-year high, halving from 403 in Q4FY23 to 206 in Q1FY24, suggesting a bullish stance. 

    Nifty500 rises to new all-time highs as PM Modi wins historic third term

    The number of stocks trading at sharp discounts fell further to 157 indicating strong bullish momentum in Q3FY24, with Nifty500 rallying by around 12% during the same quarter. This rise came after the Modi-led Bharatiya Janata Party was able to score victory in three of the four state elections in December 2023, leading to speculations of Modi easily winning a third term as Prime Minister in the upcoming Lok Sabha elections. 

    However, this bullish momentum faded in the months leading up to the election. In the chart above, we can see a bearish blip in Q4FY24 as 341 Nifty500 stocks were trading at a discount of more than 10% from their one-year highs. But, as Narendra Modi was eventually reelected as PM for his third term with the help of a coalition government, volatility returned to normal levels. More than 50% of stocks were trading near their 52-week high at the end of Q1FY25 as Nifty500 crossed the 22,500 mark.

    Currently, markets are looking bullish as only 207 of the total Nifty500 stocks are trading at a discount of more than 10% from their annual highs. The Nifty500 is poised to trade above the 23,000 level, with around 60% of its constituents trading near their one-year highs. With inflation under control, analysts expect the RBI to start the rate-cutting cycle in Q3FY25. 

    Meanwhile, keep an eye on the Q1 results coming this month, coupled with the Budget announcement due on July 23, which could determine the course of the markets going forward.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    09 Jul 2024
    Five stocks to buy from analysts this week - July 09, 2024

    Five stocks to buy from analysts this week - July 09, 2024

    By Divyansh Pokharna

    1. Mishra Dhatu Nigam:

    ICICI Direct maintains a ‘Buy’ rating on this defence stock with a target price of Rs 600, indicating a potential upside of 14.9%. Analysts Chirag Shah and Vijay Goel note that the company uses advanced manufacturing to develop a variety of special metals and alloys (like titanium, steel, and super alloys based on nickel, iron, and cobalt) for the defence, space, and energy sectors.

    Analysts observe that as of the end of May 2024, the company has an order backlog of Rs 1,767 crore, approximately 1.7 times the FY24 revenues. About 78% is from the defence sector, 12% from space, 5% from exports, and 5% from other areas. This distribution ensures strong revenue growth visibility for the next two years. The company anticipates an order inflow of Rs 1,150 crore in FY25, building on Rs 1,322 crore worth of orders received in FY24.

    Analysts Shah and Goel anticipate that the company's operational performance will improve substantially in the coming quarters, led by improvements in supply chain and inventory management. For the FY 25-26 period, they expect a CAGR of revenue/EBITDA and PAT at 23%, 41%, and 57%, respectively.

    2. Supreme Industries:

    Sharekhan maintains a ‘Buy’ rating on this plastic products company with a higher target price of Rs 6,850, indicating a potential upside of 15.5%. Supreme Industries (SIL) saw its overall volumes rise 22% YoY, with plastic pipe volumes up 27% in April-May 2024.

    The analysts foresee strong growth potential for SIL through capacity expansions and product diversification. SIL plans to expand its manufacturing capabilities by adding three new greenfield sites, bolstering its piping system capacity to 10.5 LTPA and plastic pipe system capacities to 8.4 LTPA by FY25 end. It has a committed capex of Rs 1,500 crore, covering ongoing projects and new expansions. The company's focus includes enhancing its product portfolio in protective packaging and valves, and advancing renewable energy initiatives to meet 30% of energy requirements through renewable sources by March 2025. 

    Sharekhan anticipates SIL to benefit from sustained agriculture and infrastructure demand and stabilized PVC prices. It projects a revenue CAGR of 17% and an adjusted PAT CAGR of 18.7% over FY25-27, driven by the company's internal funding for aggressive expansions.  

    3. Dabur India:

    BOB Capital maintains a ‘Buy’ rating on this personal products company, with an upgraded target price of Rs 742. This indicates a potential upside of 18.8%. Dabur’s Q1FY25 business update showed sales growth of mid to high single digits, with domestic volumes improving and earnings slightly ahead of sales growth.

    Dabur plans to accelerate sales growth through FY25, supported by government initiatives and improving rural demand post-monsoon. Analyst Lokesh Gusain has a positive outlook on Dabur and expects domestic volumes to improve further, and gross margins to expand due to stable commodity prices. The company is focused on enhancing its home and personal care (HPC) and Healthcare segments, which saw high single-digit volume growth. Dabur is also expanding its international market presence, despite currency challenges in Turkey and Egypt.

    Analyst Gusain highlights that Dabur's focus on "natural" products positions it well to benefit from rural recovery, as demand in this segment grows.  He projects a revenue CAGR of 11.1% and an adjusted PAT CAGR of 12.4% over FY25-26.

    4. BLS International:

    Edelweiss initiates a ‘Buy’ rating on this travel services firm, with a target price of Rs 518, indicating a potential upside of 36.1%. The company’s revenue grew 7.6% YoY to Rs 3,677 crore in FY24, and its net profit rose 50% YoY to Rs 313 crore, supported by strong demand in housing and infrastructure sectors.

    As the travel sector booms, BLS International plans to grow its visa and consular services by integrating new technologies.  The company is looking to expand its global footprint, particularly in Europe and North America. Analyst Nikhil Shetty is upbeat about BLSIN's cost-effective approach in offering government-to-citizen (G2C) services and managing banking correspondence. Reduction in operational expenses and tech adoption is expected to drive profitability for the company, and market share gains in the competitive visa outsourcing industry.

    Shetty sees potential in BLSIN's strategy to expand digital services and increase touch points across India, and expects this to enhance revenue and profitability in banking correspondence through value-added services (VAS). He sees the firm's profit and revenue growing at a CAGR of 34.8% and 30.1%, respectively, over FY25-26.

    5. DOMS Industries:

    Axis Direct initiates a ‘Buy’ rating on this commodity printing/stationery company with a target price of Rs 2,670, indicating a potential upside of 18.7%. Analysts Preeyam Tolia and Suhanee Shome say, “The Indian stationery and art material market is projected to grow at a 13% CAGR from FY23 to FY28, reaching Rs 71,600 crore by FY28, from Rs 38,500 crore in FY23.” DOMS Industries held a market share of 13% in FY23.

    The analysts highlight the company’s acquisition of a new 44-acre greenfield facility, which should support future growth. The company is focused on launching new products such as bags and toys and is expanding into the larger pens market instead of small pencil segments by maintaining a strategic partnership with FILA for global reach and R&D capabilities.

    Tolia and Shome expect the company to achieve CAGR growth rates of 25% for revenue, 26% for EBITDA, and 28% for PAT from FY25 to FY27. They expect EBITDA margins to range between 17% and 18% during FY 25-27, with ROCE increasing to 25% in FY27 from 22% in FY24.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    2
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    05 Jul 2024
    Five Interesting Stocks Today - July 5, 2024

    Five Interesting Stocks Today - July 5, 2024

    1. Solar Industries India:

    This industrial products company rose by 23.7% over the past week as its subsidiary Economic Explosives(EEL) launched three new explosives, SEBEX-2, SITBEX-1 and SIMEX-4 last week. These explosives are expected to improve the effectiveness of warheads, aerial bombs, underwater weapons etc. Reports suggest that the Indian Navy has completed certification tests for all three explosives and have given orders for the same. 

    For FY24, the company’s net profit increased by 10.4% YoY to Rs 835.9 crore, while its revenue declined by 12.1% YoY due a Rs 40 crore hit from hyperinflation in Ghana and Turkey, and currency depreciation (55% in Q4FY24) in Nigeria. The stock shows up in a screener for stocks with strong momentum.

    In FY24, the company’s order book surged by 74.2% YoY to Rs 5,129 crore from Rs 2,944 crore in FY23. The defense order book was at ~Rs 2,600 crore out of which Rs 1,499 crore (57.7%) were export orders. For FY25 the company’s management expects defense revenue to rise 3X and domestic explosives volume to rise by 15%. On the FY24 results Manish Nuwal, the Managing Director & CEO, is bullish about growth, saying: “In FY24, improved domestic business and increased defense sales boosted margins, achieving a record EBITDA of Rs 1,414 crore. We plan a Rs 800 crore capital expenditure in FY25 to expand production capacities, particularly in defense and explosives..” The company is investing in counter drone technology and rocket systems.

    Solar Industries says that it is in the “final stages” of negotiations for securing orders for Pinaka (multi-barrel rocket launcher) from the Indian Army and is already supplying the Nagastra1 exploding drones to the Indian Army. 

    ICICI Securities has given Solar Industries India a “Buy” rating, with a target price of Rs 13,250. The brokerage, noting the improved prospects, has raised its P/E multiple to 65x (earlier 55x) based on FY26 EPS, resulting in an upgraded target price from the previous level of Rs 11,000.

    2. Larsen & Toubro (L&T):

    This construction and engineering firm surged 6.6% in the past month after winning significant (Rs 1,000 to 2,500 crore) as well as large (Rs 2,500 to 5,000 crore) orders from ONGC, including pipeline replacements and new developments off India’s west coast. Its power transmission & distribution arm also won a significant order to build a 185MW solar plant.

    In FY24, L&T posted a revenue growth of 20.9% YoY to Rs 2,25,271 crore, with net profit growth of 24.7% YoY at Rs 13,059 crore. Trendlyne’s Forecaster estimates revenue growth of 11% YoY in Q1 FY25. The company appears in a screener of stocks with highest FII holdings.

    Order inflows for L&T surged 31.4% YoY to Rs 3,02,812 crore, with 54% being international orders, up from 38% a year ago. Its energy segment’s contribution to total order inflow increased from 13% in FY23 to 24% in FY24.CFO Shankar Raman said, “L&T expects a 10% growth in domestic order inflow for FY25 due to the government’s investment-first approach.”

    Whole-time Director & President of Energy at L&T, Subramanian Sarma said, “I think all in all, in both our core markets in the Middle East and West Asia, as well as in India, we see a large pipeline in the next 6 to 12 months.” He also highlighted the company’s focus on energy transition and green development.

    ICICI Direct maintains a ‘Buy’ rating on L&T because of the company’s focus on improving ROE to 18% by FY26 from 14.9% in FY24. They aim to achieve this through profitable bidding, on-time execution and monetising non-core assets. With a target price of Rs 4,300, L&T has a potential upside of 18.6%.

    3. Star Health and Allied Insurance:

    This general insurance company has risen by 10.7% over the past week after outlining its growth plans at its analyst day. The company aims to double its gross written premium (GWP) to Rs 30,000 crore and triple its profit after tax (PAT) to Rs 2,500 crore by FY28.

    Star Health witnessed strong growth in FY24, with a 37% YoY increase in net profit to Rs 845 crore. The company’s GWP grew by 18% YoY, benefiting from a strong market share in retail health and focused efforts on the employer-employee group segment, particularly in SMEs and MSMEs. Investments in technology, such as AI-powered fraud detection, have led to improved claim turnaround times and operational efficiency.

    During the year, it achieved a 40% growth in digital channels, with  customer-centric initiatives to improve retention and drive future growth.The company plans to expand its distribution network by adding 1 lakh agents by FY25, improving digital capabilities, and partnerships with banks, NBFCs, and corporate agents. Star Health has a strong solvency ratio of 2.2, supporting their financial strength and growth potential. CEO Anand Roy says, “We are focusing on balanced growth, splitting 50-50 between value and volume. We are expanding our agency network, digital channels, and strengthening group health. We expect a 15-25% price hike in FY25. Compared to peers, we hold a 33% market share and lead the retail health segment.”

    Motilal Oswal maintains a "Buy" rating on the stock with a target price of Rs 730. This indicates a potential upside of 24.7%. The brokerage believes Star Health's focus on high-quality business, stricter underwriting standards, and planned price increases for key products position them well to achieve their growth targets.

    4. Cello World:

    This household products manufacturer rose 3.1% and touched a 52-week high of Rs 1,025 per share on Thursday. This comes after it announced the launch of its Rs 775 crore qualified institutional placement (QIP). Cello plans to issue 86.5 lakh equity shares at a floor price of Rs 896.9. 

    The funds raised from the QIP issue will be used for various purposes, including investment in Cello Consumerware. The investment will help set up a new facility to produce stainless-steel bottles, plastic insulated ware, and household articles. Cello World will also use the funds to repay debt, and for working capital requirements.

    Over the past month, Cello World has risen by 16.3%. During FY24, the company’s revenue grew by 11.3% YoY to Rs 2,000.3 crore, driven by growth in the consumer ware segment. The segment contributes 66.2% to the total revenue. Its net profit rose 24% YoY. 

    Cello World leads in terms of market capitalization in the household products industry. The company’s peers include Carisyl and smaller players like Hardwyn India and Interiors & More. Its PE TTM stands at 63.7, compared to the industry’s 60.8.  

    During FY24, the company launched a new facility in Rajasthan with an annual capacity of around 20,000 tonnes, to expand the glassware segment. The capex for the project is Rs 250 crore. It is targeting Rs 460–475 crore in revenue from glassware and opalware in FY25. Cello plans to premiumize some of its product lines and also expand its existing portfolio by developing a new range of products. For FY25, Cello targets a 15–17% revenue growth, with EBITDA margins around 24–26%.

    Motilal Oswal believes consumption trends will remain muted in Q1 in the consumer discretionary space but sees a gradual volume recovery. The brokerage expects improved consumer demand later in the year, helped by a normal monsoon, improving macros, and continued government spending. 

    The brokerage has a ‘Buy’ rating on Cello World with a target price of Rs 1,090. The brokerage is optimistic due to the company’s plans for new product launches, inorganic acquisitions in existing segments, and expansion of the distribution network. However, the company is in the PE Strong Sell Zone indicating that it is currently trading above its historical PE.

    5. KEC International:

    This heavy electrical equipment manufacturer has risen 29.2% in the past month and hit its all-time high of Rs 968.8 on Wednesday. The price rise came after multiple order wins. It received orders worth Rs 1,017 crore for a solar PV project in Rajasthan and an EPC project in the Middle East. It also got Rs 1,025 crore worth of orders from India, Africa, and the Americas., it also announced that it had won additional orders worth Rs 2,063 crore in multiple verticals varying from T&D (transmission and distribution), railways, and cables to civil business work.

    KEC International’s current order book stands at Rs 38,000 crore, approximately 2x the FY24 revenue. It has a bid pipeline of Rs 1.3 lakh crore. The management also expects an order intake of Rs 25,000 crore in FY25. Chief Financial Officer Rajeev Aggarwal says, “We expect a 15% growth in turnover and guide for 7.5% margins for FY25 and close to double-digit margins in FY26.” The management expects its peak debt to remain at the current level of around Rs 5,000 crore; however, it expects the finance charge as a percentage of revenue to decline to 2.5% from over 3% in FY24.

    Trendlyne Forecaster estimates KEC International’s net profit to rise 4.3% in Q1FY25. In FY24, the company’s profit grew by 97% YoY to Rs 346.8 crore, while its revenue improved by 15.3% YoY. Its EBITDA margin increased by 130 basis points YoY to 6.1%. However, it missed Trendlyne Forecaster’s net profit estimate by 7.9%.

    Prabhudas Lilladher maintains a ‘Hold’ call on KEC International given its healthy execution momentum and revenue visibility from non-T&D segments. The brokerage expects growth to be driven by domestic T&D and civil businesses and expects international T&D and railways to remain soft in FY25. The company appears in a screener for stocks with increasing shareholding by foreign investors and/or institutions.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    04 Jul 2024
    A triple play: rural, renewables, and Andhra stocks | Screener: Triple-play stocks with high forecasts

    A triple play: rural, renewables, and Andhra stocks | Screener: Triple-play stocks with high forecasts

    By Swapnil Karkare

    Later this month, Finance Minister Nirmala Sitharaman will present the Budget.

    The optics may be the same -- the pink briefcase, the handloom sari -- but this time the FM is presenting a Budget on behalf of a coalition government, with somewhat different priorities.

    As a result, we have three new themes that are in focus this year for the government and investors. They are 1) the rural sector 2) renewables and 3) major companies from a particular state - Andhra Pradesh. 

    India's changed political economy is influencing two themes in particular: rural players, and Andhra Pradesh stocks. Coalition politics and upcoming state elections are pushing the government to address rural distress. Second, Andhra Pradesh has entered the spotlight with the Telugu Desam Party's (TDP) rising power at the centre and state, and its involvement in a few businesses.


    And renewables is one space where reform momentum from the previous government is likely to continue, despite coalition politics.

    In this week's Analyticks:

    • Three themes: Rural, renewables and AP stocks are in focus for investors
    • Screener: Stocks in this list likely to outperform, according to analysts

    Let's look closer.


    Are we set for a rural rebound in FY25?

    The rural economy has been taking some punches: a below-normal monsoon last year, falling agricultural growth, lower wages. The government took steps before the budget to boost this sector, by increasing MSP for crops and removing fertilisers from the GST ambit.

    The forecast this year is for a normal to above normal monsoon. So its worth keeping an eye on rural-linked sectors such as fertilisers, agrochemicals, two-wheelers, tractors, and FMCG. 

    But government action and a good monsoon are the only hopes at the moment for rural stocks. If things don’t work out here, all the gains will be wiped out. For example, although a normal monsoon was predicted, June had a deficient rainfall of around 20%. 

    The hoped-for rural revival: Is a turnaround ahead for agrochem?

    In the case of fertilizer stocks, Anand Rathi Institutional believes that the recent rally has already priced in everything – normal monsoon, GST, and subdued raw material prices. But Chambal Fertilisers, whose net profits grew double digits when its peers saw a decline, has managed the market better than others.

    Analysts like  ICICI Securities are also expecting a turnaround in agrochemicals stocks. FY24 saw an industry-wide drop in agrochemical prices and destocking in international markets. Destocking is expected to continue till the first half of FY25 in the US & Europe, and so the outlook on the domestic business is more promising than exports.

    Therefore, domestic-oriented businesses with strong fundamentals and valuations, such as Insecticides India are on the radar for analysts.

    Tractor sales are closely tracked when talking about the rural economy. But the year to date sales growth in FY25 up to May are flat. So although many analysts are optimistic, it may be too early to ride on this segment. Rajesh Jejurikar,ED & CEO, Auto & Farm Sectors, M&M, in its Q4 earnings call, said, “Cash will not come back so quickly right now, given they are coming off negative from last 4-5 months of rabi output. But there is a lot of optimism about how the second half can bounce back very strongly.”

    However, Bajaj Auto, one of the leading two-and-three-wheelers companies, is getting a boost on the valuation front amid rising two-wheeler sales.

    In the rural theme, the FMCG sector has always been one investors track when monsoons are good. In terms of strong fundamentals, Colgate-Palmolive, Emami,Nestle and Britannia top the list. And when most FMCG companies were complaining about the rural slowdown, Colgate and Emami still saw strong rural demand. Their performances could improve even further with a rural turnaround.

    Can we light up the market with renewable energy?

    Investors cannot ignore renewable energy generation, whose demand is rising sharply with a rise in electricity consumption and the goal of becoming net zero by 2070.

    India’s renewable energy capacity is estimated to reach 180 GW by 2026 from 130 GW in FY24, requiring an outlay of Rs. 3 lakh crores, according to Crisil. 

    The sector is also attractive because of the PLI scheme for solar PV module manufacturing. These facilities with a combined capacity of 39,600 MW will be operational by April 2026 in three stages. Private-sector participation through government support will keep rising in the next few years. 

    However, the sector has seen some policy flip-flops. Slow progress on the rooftop solar scheme, rising import duties on raw materials and policy changes in ALMM (Approved List of Models and Manufacturers) have created challenges for manufacturers. The export market is also a tough nut to crack: here India-made products have to compete with cheaper Chinese options, limiting market share internationally. 

    Renewable players that analysts are bullish on

    Utility stocks have had a handsome run over the past few years. However, only one stock looks well-positioned to take advantage - Tata Power.

    Analysts are bullish on both solar and wind energy. However wind power by itself is unlikely to be an attractive proposition anytime soon, overshadowed as it is by solar and its broader applicability. Tata Power’s diverse portfolio of renewables is therefore, hard to beat. Currently, 40% of its capacity constitutes clean and green energy (solar 24% and wind 7%) and it aims to increase it to 70% by 2030. It has a Rs. 13000 crores+ order book in the solar utility EPC business. It’s also ramping up solar cell and module production capacity by another 4GW. It is a leader in the rooftop solar market with a 13% share. 

    One thing to watch for is the debt levels of renewable energy players. Of Rs. 3 lakh crores of capex required for increasing India’s renewables capacity, ~70% is estimated to be met by debt funding. Tata Power’s balance sheet and credit rating would support additional borrowing, if needed.

    The kingmakers: Andhra Pradesh is in the spotlight

    When the Andhra Pradesh party TDP became a coalition partner in the new government, Economic Times mentioned a few key stocks with AP connections. The list included Heritage Foods, Amara Raja Energy, Aurobindo Pharma, Avanti Feeds, Sagar Cement, Godrej Agrovet, KNR Construction, Likhita Infra and KCP. 

    TDP chief Chandrababu Naidu’s son is a promoter of Heritage Foods. Former TDP MP Jay Dev Galla leads Amara Raja. The other stocks are based out of, or have significant operations in the state. We took a closer look at these players. It's worth keeping in mind that policy and political missteps could turn these companies sour for investors. 

    AP-linked stocks on the radar

    Amara Raja became a stock market darling over the last month, gaining ~40% driven by election results and a deal signing with GIB. Compared to its peers, it is an outlier -- although it has long-term growth drivers, its valuation is high.

    Within Andhra’s cement sector, KCP has emerged as strong performer, followed by NCL Industries. Both have lower valuations and higher EBITDA margins compared to Sagar Cements, the other Andhra-based cement company.

    In heavy-engineering companies KNR Constructions has been a performer. These three companies also have lower debt, as their debt-to-equity ratios are below 1 (0.3x, 0.3x, and 0.4x, respectively).


    Food companies like Heritage Foods and Avanti Feeds, and pharma company Natco Pharma have the edge over others in their sectors so far, based on analyst estimates, scores and FY24 ROE. 

    Stock markets don't come with guarantees. But these three themes have emerged as interesting ones as India's political and economic winds shift. The focus of the Budget will also determine how much these are worth following in the coming months.


    Screener: Rural, Andhra-linked and renewables stocks that are rising, with high Forecaster growth estimates in FY25

    FMCG stocks have risen the most in the past quarter

    We look at stocks from the three themes – rural, Telugu Desam Party (TDP)-linked, and renewables stocks – which have risen over the past quarter with analyst forecasts for strong growth in FY25. This screener shows these stocks that have risen over the past quarter with high Forecaster YoY growth estimates for revenue and EPS in FY25.

    Major stocks that appear in the screener are Heritage Foods, Emami, Chambal Fertilisers & Chemicals, Insecticides (India), Natco Pharma, Avanti Feeds, Tata Power, and Colgate Palmolive (India).

    Emami has risen by 64.5% over the past quarter. Forecaster estimates the stock’s revenue and earnings per share (EPS) will grow by 9.5% YoY and 6.1% YoY, respectively in FY25. Brokers like Sharekhan believe this packaged goods company has a strong brand portfolio, and its focus on product launches, distribution expansion, a strong pipeline of direct-to-consumer (D2C) brands, and international business will help drive growth. 

    Tata Power also features in the screener with its stock price rising 6.3% over the past quarter. Trendlyne’s Forecaster estimates this electric utilities company’s revenue and EPS to grow 10.9% and 28.9%, respectively in FY25. Geojit BNP Paribas expects the company’s performance to improve due to rising demand, capacity expansion, and promising opportunities in the rooftop solar business, renewables, and generation segments.

    You can find more screeners here.

    Copy LinkShare onShare on Share on Share on
     
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd